Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (161-170 of 785) with videos related to

Pageof 79
Sort By:
Toxins|January 19, 2019
Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over TimeDetlef H Krieter, Simon Kerwagen, Marieke Rüth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2020
Virtual reality: the dawn of a new ERAKate I Stevens, Giuseppe Palladino, Juan C Almiron, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge]Frank Weidemann, Markus Niemann, Claudia Sommer, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 10, 2018
Characterization of Fractionation Membranes in an Animal Model of Double Filtration Lipoprotein ApheresisDetlef H Krieter, Florian Lange, Horst-Dieter Lemke, et al.
European Heart Journal|July 12, 2008
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patientsKarl Winkler, Christoph Wanner, Christiane Drechsler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 27, 2010
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetesVera Krane, Mario Berger, Jürgen Lilienthal, et al.
Kidney International|September 27, 2008
Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysisVera Krane, Karl Winkler, Christiane Drechsler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2003
Identification of a new tumor suppressor gene located at chromosome 8p21.3-22Stefan Seibold, Claudia Rudroff, Manfred Weber, et al.
Contemporary Clinical Trials|May 25, 2005
Sample sizes for clinical trials with time-to-event endpoints and competing risksGabi Schulgen, Manfred Olschewski, Vera Krane, et al.
Herz|October 12, 2020
[Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms : A systematic review]Andreas J Rieth, Christian W Hamm, Christoph Wanner, et al.
Pageof 79

Showing results (161-170 of 785) with videos related to

Sort By:
Pageof 79
Toxins|January 19, 2019
Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over TimeDetlef H Krieter, Simon Kerwagen, Marieke Rüth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2020
Virtual reality: the dawn of a new ERAKate I Stevens, Giuseppe Palladino, Juan C Almiron, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge]Frank Weidemann, Markus Niemann, Claudia Sommer, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 10, 2018
Characterization of Fractionation Membranes in an Animal Model of Double Filtration Lipoprotein ApheresisDetlef H Krieter, Florian Lange, Horst-Dieter Lemke, et al.
European Heart Journal|July 12, 2008
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patientsKarl Winkler, Christoph Wanner, Christiane Drechsler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 27, 2010
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetesVera Krane, Mario Berger, Jürgen Lilienthal, et al.
Kidney International|September 27, 2008
Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysisVera Krane, Karl Winkler, Christiane Drechsler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2003
Identification of a new tumor suppressor gene located at chromosome 8p21.3-22Stefan Seibold, Claudia Rudroff, Manfred Weber, et al.
Contemporary Clinical Trials|May 25, 2005
Sample sizes for clinical trials with time-to-event endpoints and competing risksGabi Schulgen, Manfred Olschewski, Vera Krane, et al.
Herz|October 12, 2020
[Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms : A systematic review]Andreas J Rieth, Christian W Hamm, Christoph Wanner, et al.
Pageof 79